Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): early-phase trial registry
A small indexed set (3 trials) with no open enrollment listed right now.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · none currently recruiting · #5,209 of 28,707 conditions by registered trial count
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): 3 US clinical trials tracked, none currently recruiting.
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is the subject of 3 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 1 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is argenx, running 2 of these trials.
Enrollment posture brief
Registry condition chronic-inflammatory-demyelinating-polyneuropathy-cidp
OPEN 0 | RECR 0% | LATE 1 | EARLY 2 | RANK #5209 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) has no open enrollment in this registry pull (3 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is recruiting below its size-band peers.
0 of 3 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Indexed trials (enrollment closed)
3 total, page 1 of 1
A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP, an Autoimmune Disorder That Affects the Peripheral Nerves)
argenx
NCT04280718
A Study to Assess the Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP, an Autoimmune Disorder That Affects the Peripheral Nerves)
argenx
NCT04281472
Extension Study of Maintenance Treatment With Subcutaneous Immunoglobulin (IgPro20) for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
CSL Behring
NCT02027701
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 2 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) page
3 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- No Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- argenx sponsors the most Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) trials on record, review their full trial history before evaluating a specific study. See argenx's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) condition card totals 3 registered trials; most-linked intervention IgPro20; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.